单核细胞与高密度脂蛋白胆固醇比值(MHR)、Gensini评分在急性冠脉综合征中研究进展
The Monocyte-to-High-Density Lipoprotein Cholesterol Ratio (MHR) and Gensini Score in Acute Coronary Syndrome
DOI: 10.12677/acm.2025.15113127, PDF,   
作者: 雷顺忠:内蒙古民族大学第二临床医学院(内蒙古林业总医院),内蒙古 呼伦贝尔;孔令阁*:内蒙古林业总医院心血管内科,内蒙古 呼伦贝尔
关键词: 单核细胞与高密度脂蛋白胆固醇比值(MHR)Gensini评分急性冠脉综合征(ACS)The Monocyte-to-High-Density Lipoprotein Cholesterol Ratio (MHR) Gensini Score Acute Coronary Syndrome (ACS)
摘要: 单核细胞与高密度脂蛋白胆固醇比值(MHR)是衡量脂质代谢和炎症的新型生物标志物,Gensini评分是一种量化冠状动脉狭窄程度与分布的评分系统,在急性冠脉综合征(ACS)的发生、严重程度和预后等方面作用显著。该文介绍MHR、Gensini评分在ACS中的应用。
Abstract: The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) is a novel biomarker for assessing lipid metabolism and inflammation. The Gensini score is a scoring system for quantifying the degree and distribution of coronary artery stenosis, and it plays a significant role in the occurrence, severity, and prognosis of acute coronary syndrome (ACS). This article introduces the application of MHR and Gensini score in ACS.
文章引用:雷顺忠, 孔令阁. 单核细胞与高密度脂蛋白胆固醇比值(MHR)、Gensini评分在急性冠脉综合征中研究进展[J]. 临床医学进展, 2025, 15(11): 528-534. https://doi.org/10.12677/acm.2025.15113127

参考文献

[1] 孙丽娜, 杨玲, 杜雪平. 急性冠脉综合征患者的社区心脏康复现状与发展[J]. 中华全科医师杂志, 2019, 18(6): 596-599.
[2] Falk, E., Nakano, M., Bentzon, J.F., Finn, A.V. and Virmani, R. (2013) Update on Acute Coronary Syndromes: The Pathologists’ View. European Heart Journal, 34, 719-728. [Google Scholar] [CrossRef] [PubMed]
[3] Libby, P., Ridker, P.M. and Maseri, A. (2002) Inflammation and Atherosclerosis. Circulation, 105, 1135-1143. [Google Scholar] [CrossRef] [PubMed]
[4] Huang, Y., Liu, A., Ji, H., et al. (2020) The Relationship between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Coronary Artery Disease Severity Assessed by Gensini Score in Patients with Acute Coronary Syndrome. Clinical Cardiology, 43, 1032-1039.
[5] Li, S., Yang, Y., Li, W., et al. (2021) Monocyte to HDL Cholesterol Ratio Predicts Adverse Cardiovascular Outcomes in Patients with ST-Elevation Myocardial Infarction after Primary PCI. Cardiology Journal, 28, 836-844.
[6] Chen, Q., Li, H., Zhang, Y., et al. (2022) Prognostic Value of Monocyte to HDL Cholesterol Ratio in Patients with Acute coronary Syndrome: A Meta-Analysis. Frontiers in Cardiovascular Medicine, 9, Article ID: 835276.
[7] Wynn, T.A. and Vannella, K.M. (2016) Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity, 44, 450-462. [Google Scholar] [CrossRef] [PubMed]
[8] Woollard, K.J. and Geissmann, F. (2010) Monocytes in Atherosclerosis: Subsets and Functions. Nature Reviews Cardiology, 7, 77-86. [Google Scholar] [CrossRef] [PubMed]
[9] Tabas, I. and Bornfeldt, K.E. (2023) Macrophages in the Pathogenesis of Atherosclerosis. Cell, 186, 5437-5454.
[10] Lee, J.H., Han, K.D., Jung, J.H., et al. (2016) Monocyte Count as a Predictor of Cardiovascular Mortality in Older Korean People. Age and Ageing, 45, 825-830.
[11] Grao-Cruces, E., Lopez-Enriquez, S., Martin, M.E. and Montserrat-de la Paz, S. (2022) High-Density Lipoproteins and Immune Response: A Review. International Journal of Biological Macromolecules, 195, 117-123. [Google Scholar] [CrossRef] [PubMed]
[12] Besler, C., Luscher, T.F. and Landmesser, U. (2012) Molecular Mechanisms of Vascular Effects of High-Density Lipoprotein: Alterations in Cardiovascular Disease. Circulation Research, 109, 1124-1148.
[13] Denimal, D., Pais de Barros, J.P., Bouillet, B. and Verges, B. (2023) Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes. Antioxidants, 13, Article 57. [Google Scholar] [CrossRef] [PubMed]
[14] Bonacina, F., Pirillo, A., Catapano, A.L. and Norata, G.D. (2021) HDL in Immune-Inflammatory Responses: Implications Beyond Cardiovascular Diseases. Cells, 10, Article 1061. [Google Scholar] [CrossRef] [PubMed]
[15] Jia, C., Anderson, J.L.C., Gruppen, E.G., Lei, Y., Bakker, S.J.L., Dullaart, R.P.F., et al. (2021) High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events. Circulation, 143, 1935-1945. [Google Scholar] [CrossRef] [PubMed]
[16] Ansell, B.J., Fonarow, G.C. and Fogelman, A.M. (2007) The Paradox of Dysfunctional High-Density Lipoprotein. Cleveland Clinic Journal of Medicine, 74, 697-705.
[17] Ma, X., Han, K., Yang, L., Shao, Q., Li, Q., Wang, Z., et al. (2022) Adjustment of the GRACE Risk Score by Monocyte to High-Density Lipoprotein Ratio Improves Prediction of Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Frontiers in Cardiovascular Medicine, 8, Article ID: 755806. [Google Scholar] [CrossRef] [PubMed]
[18] Tharuni Latha, A., Nagesh, G.N., Gandhi, P.R., Jose, A., Salih, H. and Rachitha, S. (2019) Elevated Monocyte to HDL Cholesterol Ratio as a New Inflammatory Marker in Smokers. Journal of Medical Science and Clinical Research, 7, 949-953.
[19] Jiang, M., Yang, J., Zou, H., Li, M., Sun, W. and Kong, X. (2022) Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio (MHR) and the Risk of All-Cause and Cardiovascular Mortality: A Nationwide Cohort Study in the United States. Lipids in Health and Disease, 21, Article No. 67. [Google Scholar] [CrossRef] [PubMed]
[20] 葛小明, 兰永昊, 周玉杰, 等. 单核细胞/高密度脂蛋白胆固醇比值与急性冠状动脉综合征患者冠状动脉SYNTAX评分的相关性分析[J]. 中国医药, 2022, 17(7): 975-978.
[21] Meng, H., Zhou, X., Li, L., Liu, Y., Liu, Y. and Zhang, Y. (2024) Monocyte to High-Density Lipoprotein Cholesterol Ratio Predicts Restenosis of Drug-Eluting Stents in Patients with Unstable Angina Pectoris. Scientific Reports, 14, Article No. 2644. [Google Scholar] [CrossRef] [PubMed]
[22] Rampidis, G.P., Benetos, G., Benz, D.C., Giannopoulos, A.A. and Buechel, R.R. (2019) A guide for Gensini Score calculation. Atherosclerosis, 287, 181-183. [Google Scholar] [CrossRef] [PubMed]
[23] Gensini, G.G. (1983) A More Meaningful Scoring System for Determining the Severity of Coronary Heart Disease. The American Journal of Cardiology, 51, Article 606. [Google Scholar] [CrossRef] [PubMed]
[24] Pope, J.H., Aufderheide, T.P., Ruthazer, R., Woolard, R.H., Feldman, J.A., Beshansky, J.R., et al. (2000) Missed Diagnoses of Acute Cardiac Ischemia in the Emergency Department. New England Journal of Medicine, 342, 1163-1170. [Google Scholar] [CrossRef] [PubMed]
[25] Björck, L., Nielsen, S., Jernberg, T., Zverkova-Sandström, T., Giang, K.W. and Rosengren, A. (2018) Absence of Chest Pain and Long-Term Mortality in Patients with Acute Myocardial Infarction. Open Heart, 5, e000909. [Google Scholar] [CrossRef] [PubMed]
[26] Karim, K., Aulia, M.S., Pradisa, I.S., Huda, M.F., Setyasari, A., Yosephina, S., et al. (2023) Monocyte to High-Density Lipoprotein Cholesterol Ratio as Highly Predictive Marker in Patients with Acute Coronary Syndrome. Future Cardiology, 19, 261-270. [Google Scholar] [CrossRef] [PubMed]
[27] Cetin, M.S., Ozcan Cetin, E.H., Kalender, E., Aydin, S., Topaloglu, S., Kisacik, H.L., et al. (2016) Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart, Lung and Circulation, 25, 1077-1086. [Google Scholar] [CrossRef] [PubMed]
[28] He, L., Chen, S., Zhu, X. and He, F. (2025) The Change of Inflammatory Markers May Predict Long-Term Major Adverse Cardiovascular Events in Elderly Patients with Coronary Heart Disease: A Retrospective Cohort Study. Frontiers in Medicine, 11, Article ID: 1523581. [Google Scholar] [CrossRef] [PubMed]
[29] Du, G., Liu, F., Liu, H., Meng, Q., Tang, R., Li, X., et al. (2023) Monocyte-to-High Density Lipoprotein Cholesterol Ratio Positively Predicts Coronary Artery Disease and Multi-Vessel Lesions in Acute Coronary Syndrome. International Journal of General Medicine, 16, 3857-3868. [Google Scholar] [CrossRef] [PubMed]
[30] Shu, H., Han, S., Qiu, W., Li, J., Zhang, X., Su, H., et al. (2025) Association of the Monocyte to High-Density Lipoprotein Cholesterol Ratio and Neutrophil to High-Density Lipoprotein Cholesterol Ratio with the Severity of New-Onset Coronary Artery Disease. Journal of Inflammation Research, 18, 463-476. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, J., Wu, K., Cao, W., Shao, J. and Huang, M. (2023) Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Multi-Vessel Coronary Artery Disease: A Cross-Sectional Study. Lipids in Health and Disease, 22, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
[32] Wu, T., Zheng, Y., Chen, Y., Yu, Z., Ma, Y. and Xie, X. (2019) Monocyte to High-Density Lipoprotein Cholesterol Ratio as Long-Term Prognostic Marker in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Lipids in Health and Disease, 18, Article No. 180. [Google Scholar] [CrossRef] [PubMed]
[33] Chen, B., Liu, J., Xing, J., Liu, H., Wei, Y., Xue, X., et al. (2022) Analysis of the Correlation between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and In-Stent Restenosis in Patients with Premature Coronary Heart Disease. Clinical and Applied Thrombosis/Hemostasis, 28, Article 10760296221079334. [Google Scholar] [CrossRef] [PubMed]
[34] Pruc, M., Kubica, J., Banach, M., Świeczkowski, D., Rafique, Z., Peacock, W.F., et al. (2025) Prognostic Value of the Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio in Acute Coronary Syndrome Patients: A Systematic Review and Meta-Analysis. Polish Heart Journal, 83, 52-61. [Google Scholar] [CrossRef] [PubMed]
[35] Yu, R., Hou, R., Wang, T., Li, T., Han, H. and An, J. (2021) Correlation between Monocyte to High-Density Lipoprotein Ratio and Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention. Pakistan Journal of Medical Sciences, 37, 1076-1082. [Google Scholar] [CrossRef] [PubMed]
[36] Wang, Y., Duan, J., Nagraj, S., Kim, Y.H. and Pan, Y. (2025) The Value of the Monocyte to High-Density Lipoprotein Cholesterol Ratio in Predicting the Thrombosis Burden and Long-Term Prognosis of Acute Myocardial Infarction Patients: A Retrospective Cohort Study. Journal of Thoracic Disease, 17, 3370-3379. [Google Scholar] [CrossRef] [PubMed]
[37] Wu, T.T., Qi, X.Y., et al. (2019) Monocyte to High-Density Lipoprotein Cholesterol Ratio as a Predictor of Long-Term Outcome in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. BMC Cardiovascular Disorders, 19, Article No. 77.
[38] 王露朝, 等. 老年STEMI/ACS患者中MHR与Gensini评分及远期预后的相关研究[J]. 中华心血管病杂志, 2022, 50(4): 400-406.